Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben M Dunn

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Biochemistry|November 17, 2007
Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteasesRebecca E Moose, José C Clemente, Larry R Jackson, et al.
Biochemistry|March 11, 2009
Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysisPeng Liu, Melissa R Marzahn, Arthur H Robbins, et al.
Journal of Medicinal Chemistry|January 25, 2008
Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutationJosé C Clemente, Arthur Robbins, Paula Graña, et al.
FEBS Letters|July 2, 2014
Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational samplingJeffrey D Carter, Estrella G Gonzales, Xi Huang, et al.
The Journal of Biological Chemistry|September 1, 2016
Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure EvolutionZhanglong Liu, Xi Huang, Lingna Hu, et al.
AIDS (London, England)|July 24, 2009
Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitorSarah K Ho, Elena E Perez, Stephanie L Rose, et al.
Biochemistry|April 26, 2006
Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavirJosé C Clemente, Roxana M Coman, Michele M Thiaville, et al.
Bioorganic & Medicinal Chemistry|July 10, 2018
Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitorsAmit Kumar Singh, Vinoth Rajendran, Snigdha Singh, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 3, 2006
Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitorJosé C Clemente, Lakshmanan Govindasamy, Amrita Madabushi, et al.
Plos Pathogens|May 17, 2014
Mycobacterium tuberculosis Hip1 modulates macrophage responses through proteolysis of GroEL2Jacqueline L Naffin-Olivos, Maria Georgieva, Nathan Goldfarb, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Biochemistry|November 17, 2007
Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteasesRebecca E Moose, José C Clemente, Larry R Jackson, et al.
Biochemistry|March 11, 2009
Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysisPeng Liu, Melissa R Marzahn, Arthur H Robbins, et al.
Journal of Medicinal Chemistry|January 25, 2008
Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutationJosé C Clemente, Arthur Robbins, Paula Graña, et al.
FEBS Letters|July 2, 2014
Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational samplingJeffrey D Carter, Estrella G Gonzales, Xi Huang, et al.
The Journal of Biological Chemistry|September 1, 2016
Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure EvolutionZhanglong Liu, Xi Huang, Lingna Hu, et al.
AIDS (London, England)|July 24, 2009
Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitorSarah K Ho, Elena E Perez, Stephanie L Rose, et al.
Biochemistry|April 26, 2006
Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavirJosé C Clemente, Roxana M Coman, Michele M Thiaville, et al.
Bioorganic & Medicinal Chemistry|July 10, 2018
Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitorsAmit Kumar Singh, Vinoth Rajendran, Snigdha Singh, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 3, 2006
Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitorJosé C Clemente, Lakshmanan Govindasamy, Amrita Madabushi, et al.
Plos Pathogens|May 17, 2014
Mycobacterium tuberculosis Hip1 modulates macrophage responses through proteolysis of GroEL2Jacqueline L Naffin-Olivos, Maria Georgieva, Nathan Goldfarb, et al.
Pageof 9